Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
Member count: 1-10
Investors 2
| Date | Name | Website |
| - | Logos Capi... | logoscapit... |
| - | RA Capital... | racap.com |